It is one of GSK's top drugs, with sales of $2.2 billion last year, jostling for market share with other IL-5 inhibitors, notably AstraZeneca's Fasenra (benralizumab) – dosed every four weeks ...

More than 50% of patients with severe asthma have high eosinophil levels, making them candidates for biologic therapies like Nucala and other drugs like AstraZeneca’s Fasenra (benralizumab ...

Emphysematous changes refer to changes that may occur in the lungs as emphysema progresses and are visible on a CT scan. This may include changes in location or the type of damage in the lungs due ...

Roshni Naik, MD, allergist at Mount Sinai Health System, discusses the history of present illness for a case of severe asthma with nasal polyps: "Patient is a 45 year-old male with a past medical ...

Share price of Indo Count Industries tanked 17 per cent at ₹241.10 on the BSE in Monday’s intra-day trade after the company reported a sharp 88 per cent decline in its consolidated profit after tax ...

In the past two weeks, the stock price of Cosmo First, a global leader in films for packaging, lamination, labeling and synthetic paper, has rallied 82% after the firm reported strong Q4 earnings.